Alyeska Investment Group’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-45,000
Closed -$688K 496
2022
Q2
$688K Hold
45,000
0.01% 515
2022
Q1
$1.03M Hold
45,000
0.01% 491
2021
Q4
$1.66M Buy
+45,000
New +$1.66M 0.02% 469
2021
Q3
Sell
-100,000
Closed -$6.03M 800
2021
Q2
$6.03M Buy
+100,000
New +$6.03M 0.07% 300